Corgenix Medical Corporation

Terms include initial US$1.25 million ELITech equity investment in Corgenix with options for US$3 million total, plus distribution agreement and diagnostic system co-development

Older News

DENVER and PARIS, July 19, 2010 - Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and the ELITech Group, a Paris, France-based, privately held group of companies and worldwide manufacturer and distributor of in-vitro diagnostic equipment and reagents, today announced a broad strategic alliance.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy